A. A. Tukhbatova

A. A. Tukhbatova

Auto-generated profile, based on publicly available information

A. A. Tukhbatova

Samara State Medical University; Polyakov Samara Regional Clinical Cardiology Dispensary

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2026 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
Dmitry V. DuplyakovDmitry V. Duplyakov
Dmitry V. Duplyakov
DSD. A. Shebonkina
D. A. Shebonkina
AUA. E. Uranov
A. E. Uranov
IMI. L. Mikheenko
I. L. Mikheenko
KAK. S. Astrakova
K. S. Astrakova
Denis LosikDenis Losik
Denis Losik
Aim . To evaluate the impact of a clinical decision support system (CDSS) in the management of patients with hypertension (HTN) and atrial fibrillation (AF) on compliance with clinical guidelines in real-world clinical practice. Material and methods. A cluster-randomized comparative study was conducted in 8 internal medicine departments in Samara. The departments were randomized into two following groups: one with the CDSS for prescribing anticoagulant, antiarrhythmic, and antihypertensive therapy (n=3; 2 inpatient and 1 outpatient department) and one without the CDSS — routine clinical practice (n=5; 3 inpatient and 2 outpatient departments). The study included patients with both hypertension and AF. The mean follow-up period was 11,5±5,7 months. R e sults . The study included 272 patients. Prescription rate of reduced doses of direct oral anticoagulants was significantly lower in the CDSS group as follows: apixaban 2,5 mg (0,8% vs 4,4%, p<0,001) and rivaroxaban 15 mg (4,2% vs 15%, p<0,001). In the CDSS group, amiodarone was prescribed significantly less frequently for rhythm control (3,6% vs 30%, p<0,001), and catheter ablation were performed more frequently (16% vs 5%, p=0,014). With the use of CDSS, the proportion of patients with cardiovascular events (CVEs) during the 12-month follow-up period decreased (4,2% vs 13,9%; when converted to 10 patient-years, 0,39 and 1,71, p<0,001). Conclusion . CDSS implementation demonstrated a significant improvement in physician compliance with clinical guidelines in terms of prescribing optimal anticoagulant and antiarrhythmic therapy. Patients were more frequently referred for catheter ablation of AF. CDSS is associated with a reduced incidence of CVEs in patients with hypertension and AF.

15 July 2025 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
GBG. R. Bikbaeva
G. R. Bikbaeva
AKAnna Kovalskaya
Anna Kovalskaya
KKK. V. Kuznetsova
K. V. Kuznetsova
PDP. D. Duplyakova
P. D. Duplyakova
ATA. A. Tukhbatova
A. A. Tukhbatova
ЕСЕкатерина Савинова
Екатерина Савинова
Aim. To assess the detection rate of vulnerable plaques using computed tomography (CT) in patients after acute coronary syndrome (ACS) and percutaneous coronary intervention (PCI).Material and methods. The study included 125 patients with ACS who underwent PCI (men, 68%; median age, 59 (51-66) years). One month after the index event, patients who did not achieve target low-density lipoprotein cholesterol values were divided into two groups depending on the signs of vulnerable plaques according to CT data.Results. Vulnerable plaques were detected in 56 (44,8%) patients using CT (69,6% men, median age 60 (51-63) years). Patients with vulnerable plaques were more likely to have right coronary artery (CA) involvement — 53,6 vs 11,6% (p<0,001); left main CA — 33,9 vs 5,8% (p<0,001); left anterior descending artery — 76,8 vs 15,9% (p<0,001); circumflex artery — 48,2 vs 18,8% (p<0,001) compared to patients without vulnerable plaques. The coronary calcium index in patients with vulnerable plaques was significantly higher — 111 (29-247) vs 35 (1-138) (p=0,003). Patients with signs of vulnerable plaques had more severe coronary artery disease according to the segment-stenosis (SSS) and segment-involvement (SIS) scores — 3 (1-4) vs 0 (0-1) (p<0,001) compared to patients without vulnerable plaques.Conclusion. The detection rate of vulnerable plaques in patients after ACS and PCI not achieved target LDL values while receiving highdose statin therapy was 44,8%. Patients with vulnerable plaques were characterized by more spread atherosclerotic coronary involvement and a high calcium index.

15 July 2025 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Closed access
GBG. R. Bikbaeva
G. R. Bikbaeva
AKAnna Kovalskaya
Anna Kovalskaya
KKK. V. Kuznetsova
K. V. Kuznetsova
PDP. D. Duplyakova
P. D. Duplyakova
ATA. A. Tukhbatova
A. A. Tukhbatova
ЕСЕкатерина Савинова
Екатерина Савинова
Aim. To assess the detection rate of vulnerable plaques using computed tomography (CT) in patients after acute coronary syndrome (ACS) and percutaneous coronary intervention (PCI). Material and methods. The study included 125 patients with ACS who underwent PCI (men, 68%; median age, 59 (51-66) years). One month after the index event, patients who did not achieve target low-density lipoprotein cholesterol values were divided into two groups depending on the signs of vulnerable plaques according to CT data. Results. Vulnerable plaques were detected in 56 (44,8%) patients using CT (69,6% men, median age 60 (51-63) years). Patients with vulnerable plaques were more likely to have right coronary artery (CA) involvement — 53,6 vs 11,6% (p<0,001); left main CA — 33,9 vs 5,8% (p<0,001); left anterior descending artery — 76,8 vs 15,9% (p<0,001); circumflex artery — 48,2 vs 18,8% (p<0,001) compared to patients without vulnerable plaques. The coronary calcium index in patients with vulnerable plaques was significantly higher — 111 (29-247) vs 35 (1-138) (p=0,003). Patients with signs of vulnerable plaques had more severe coronary artery disease according to the segment-stenosis (SSS) and segment-involvement (SIS) scores — 3 (1-4) vs 0 (0-1) (p<0,001) compared to patients without vulnerable plaques. Conclusion. The detection rate of vulnerable plaques in patients after ACS and PCI not achieved target LDL values while receiving highdose statin therapy was 44,8%. Patients with vulnerable plaques were characterized by more spread atherosclerotic coronary involvement and a high calcium index.

1 January 2022 in Medical Science And Education Of Ural
Verified
Journal Article
Closed access
LSLiliyana M. Saptarova
Liliyana M. Saptarova
EIElvira A. Imelbaeva
Elvira A. Imelbaeva
GSGulnara F. Shakirova
Gulnara F. Shakirova
ATAliya V. Tukhbatova
Aliya V. Tukhbatova
DBDina E. Bayburina
Dina E. Bayburina
SGShamil N. Galimov
Shamil N. Galimov

4 October 2026 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
GBG. R. Bikbaeva
G. R. Bikbaeva
AKAnna Kovalskaya
Anna Kovalskaya
KKK. V. Kuznetsova
K. V. Kuznetsova
PDP. D. Duplyakova
P. D. Duplyakova
ATA. A. Tukhbatova
A. A. Tukhbatova
ДДД. В. Дупляков
Д. В. Дупляков
Aim. To evaluate the potential of high-dose combination lipid-lowering therapy (LLT) in reducing coronary atherosclerosis in patients after acute coronary syndrome (ACS), depending on the presence of vulnerable plaques (VPs). Material and methods . The study included 125 patients (men, 68%; mean age, 56,9±9,8 years) after ACS and percutaneous coronary intervention. After one month of treatment, coronary computed tomography angiography (CCTA) was performed, and the patients were randomized into two groups depending on VP presence. After 12 months, a repeat CCTA was performed during LLT. Results. Combined LLT resulted in a significant decrease in VP criteria as follows: Me (Q 1 ;Q 3 ), 2 (1;4) vs 2 (1;2), p=0,002. In the group of patients with VP, the prevalence of atherosclerosis in the following coronary arteries was significantly reduced: the left main coronary artery (p=0,008), the left anterior descending artery (p=0,002), and the circumflex artery (p=0,016). A significant decrease in the SSS and SIS scales was also noted between visits 2 and 6 in the group with VP — Me (Q 1 ;Q 3 ), 3 (1;4) vs 2 (1;4), p<0,001. The coronary calcium index in the group with VP was higher than in the group without VP both at visit 2: Me (Q 1 ;Q 3 ), 35 (1;138) vs 111 (29;247), p=0,004, and at visit 6: Me (Q 1 ;Q 3 ), 35 (0;178) vs 105 (31;245), p=0,008. After 1-year therapy, a significant decrease in the level of total cholesterol (p<0,001), low-density lipoproteins (p<0,001) and triglycerides (p<0,001 vs p=0,002) was noted in each group without a negative effect on safety markers. Within each group, characteristic signs of a decrease in lipid levels were recorded between visits 2 and 6, while no indicators were detected in the intergroup comparison of these indicators at visits 2 and 6. Conclusion . Combined LLT after ACS leads to a significant reduction in the severity of coronary atherosclerosis, as measured by CCTA and SIS and SSS scales, due to VP stabilization.

3 May 2025 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
DGD. A. Grabovyi
D. A. Grabovyi
GBG. R. Bikbaeva
G. R. Bikbaeva
IOI. A. Osadchii
I. A. Osadchii
ATA. A. Tukhbatova
A. A. Tukhbatova
Dmitry V. DuplyakovDmitry V. Duplyakov
Dmitry V. Duplyakov
More than 100 million women use combined oral contraceptives to prevent unintended pregnancy, as well as for a number of other medical indications. Taking estrogen and progestin drugs is associated with the risk of acute thromboembolic and vascular events. This is a consequence of an increase in serum coagulation factors and a direct effect on endothelial dysfunction, which enhances platelet aggregation. This article demonstrates the development of myocardial infarction and pulmonary embolism in a young man during feminizing therapy.